GlassScriptPhysician profile
Olga Brusil
NPI 1730275223
$6,432.55
in general payments reported to CMS, 2019-2025
52 companies · $1,402 in 2025
The $1,402 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $93.41 · 2021: $1,012 · 2022: $1,619 · 2023: $1,395 · 2024: $911 · 2025: $1,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,608 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,607.93 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $757.87 | 2021-2025 | Duopa, Botox, Qulipta |
| Argenx US, INC. | $656.56 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Ucb, INC. | $473.90 | 2021-2025 | Rystiggo, Nayzilam, Briviact |
| Alexion Pharmaceuticals, INC. | $452.90 | 2021-2025 | Ultomiris |
| Neurocrine Biosciences, INC. | $323.27 | 2020-2025 | Ingrezza, Ongentys |
| Biogen, INC. | $299.44 | 2021-2024 | Spinraza, Spinraza |
| Amneal Pharmaceuticals LLC | $243.34 | 2021-2025 | Rytary, Crexont |
| Teva Pharmaceuticals USA, INC. | $242.73 | 2020-2025 | Austedo Xr, Austedo Xr |
| Novartis Pharmaceuticals Corporation | $242.08 | 2021-2025 | |
| Janssen Biotech, INC. | $186.63 | 2025 | |
| Sk Life Science, INC. | $186.07 | 2021-2025 | |
| Pfizer INC. | $140.65 | 2023-2025 | |
| Lundbeck LLC | $107.35 | 2021-2025 | Rexulti |
| Abbott Laboratories | $106.40 | 2022-2025 | Infinity |
| Biohaven Pharmaceutical Holding Company LTD. | $105.66 | 2022 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $102.90 | 2023-2025 | Qutenza |
| Medtronic, INC. | $98.61 | 2023-2025 | Activa PC, Linq II |
| Ge Healthcare | $94.51 | 2020-2024 | |
| Boston Scientific Corporation | $89.93 | 2023-2024 | Vercise |
| Biohaven Pharmaceuticals, INC. | $84.23 | 2021 | |
| Avion Pharmaceuticals | $81.48 | 2022-2023 | Dhivy |
| Eisai INC. | $76.76 | 2025 | |
| Grifols USA, LLC | $74.72 | 2021-2025 | Gamunex-C |
| Corium, LLC | $72.33 | 2022-2023 | Adlarity |
| Kyowa Kirin, INC. | $69.90 | 2021-2024 | Nourianz |
| Banner Life Sciences, LLC | $65.30 | 2021-2022 | |
| Csl Behring | $62.03 | 2023 | Hizentra |
| Tanabe Pharma America, INC. | $61.65 | 2022-2025 | Radicava |
| Lilly USA, LLC | $60.71 | 2022-2023 | Emgality, Reyvow |
| Amgen INC. | $58.38 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.94 | 2023-2024 | Hyqvia |
| Inspire Medical Systems, INC. | $52.33 | 2024-2025 | Inspire |
| Catalyst Pharmaceuticals, INC. | $50.88 | 2022-2023 | Firdapse |
| Supernus Pharmaceuticals, INC. | $46.66 | 2022-2025 | Qelbree |
| Axsome Therapeutics, INC. | $46.02 | 2023-2025 | Symbravo, Sunosi |
| Collegium Pharmaceutical, INC. | $45.96 | 2022 | |
| Allergan, INC. | $44.56 | 2022 | |
| Grt US Holding, INC. | $39.94 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $39.45 | 2023 | Nuedexta |
| Livanova USA, INC. | $38.49 | 2022-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Arbor Pharmaceuticals, INC. | $37.59 | 2021 | |
| Upsher-Smith Laboratories LLC | $35.40 | 2020-2021 | |
| Merz Pharmaceuticals, LLC | $35.33 | 2025 | Xeomin |
| Celgene Corporation | $32.39 | 2021-2023 | Zeposia |
| Alnylam Pharmaceuticals INC. | $27.85 | 2022 | |
| Acadia Pharmaceuticals INC | $25.59 | 2024 | Nuplazid |
| Scilex Pharmaceuticals INC. | $18.41 | 2024 | |
| Janssen Pharmaceuticals, INC | $18.30 | 2022 | |
| Azurity Pharmaceuticals, INC. | $16.98 | 2025 | |
| Insightec,INC | $16.03 | 2024 | Exablate |
| Aquestive Therapeutics, INC. | $15.92 | 2020 | |
| Impel Pharmaceuticals INC. | $15.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Brusil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.